Cargando…
LncRNAs in Non-Small-Cell Lung Cancer
Lung cancer is associated with a high mortality, with around 1.8 million deaths worldwide in 2018. Non-small-cell lung cancer (NSCLC) accounts for around 85% of cases and, despite improvement in the management of NSCLC, most patients are diagnosed at advanced stage and the five-year survival remains...
Autores principales: | Ginn, Lucy, Shi, Lei, La Montagna, Manuela, Garofalo, Michela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549371/ https://www.ncbi.nlm.nih.gov/pubmed/32629922 http://dx.doi.org/10.3390/ncrna6030025 |
Ejemplares similares
-
Potential clinical application of lncRNAs in non-small cell lung cancer
por: Lu, Tong, et al.
Publicado: (2018) -
LncRNAs and CircRNAs in cancer
por: Yin, Xin, et al.
Publicado: (2022) -
Associating lncRNAs with small molecules via bilevel optimization reveals cancer-related lncRNAs
por: Wang, Yongcui, et al.
Publicado: (2019) -
Exosome-Derived LncRNAs in Lung Cancer
por: Fan, Tao, et al.
Publicado: (2020) -
Construction of a prognostic signature of autophagy-related lncRNAs in non-small-cell lung cancer
por: Zhang, Xinyang, et al.
Publicado: (2021)